0

Global Retinal Vein Occlusion Therapeutics Market 2019-2023

  • Published: Oct 2018
  • Pages: 119
  • SKU: IRTNTR30039
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The global retinal vein occlusion therapeutics market size will grow by USD 1.53 billion during 2019-2023. This industry research report provides a detailed analysis of the market based on type [branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO)] and geography (the Americas, APAC and EMEA). The report analyzes the market’s competitive landscape and offers information on several retinal vein occlusion therapeutics companies including Allergan, Bayer, F. Hoffmann-La Roche, Novartis and Regeneron Pharmaceuticals.

What will the Retinal Vein Occlusion Therapeutics Market Size be in 2019?

Global Retinal Vein Occlusion Therapeutics Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

How will Recent Drug Approvals Influence Retinal Vein Occlusion Therapeutics Market Growth?

The presence of a strong pipeline and the recent drug approvals will drive global retinal vein occlusion market growth. There is an increase in the number of retinal vein occlusion cases and there is a rise in the number of molecules that are under development for the treatment. With the presence of a strong pipeline and the recent drug approvals, the efficiency of retinal vein occlusion treatment is increasing. This, in turn, will the adoption of retinal vein occlusion therapeutics, driving market growth.

Advancements in drug delivery technologies are positively impacting the global retinal vein occlusion therapeutics market. Advanced drug delivery technologies come with several advantages including reduction in the number and frequency of doses required to maintain the desired therapeutic response, lower health care costs, and preferable patient compliance. Such advantages will increase end-user preference towards advanced drug delivery technologies in retinal vein occlusion therapeutics, driving market growth. The presence of strong pipeline and recent drug approvals, coupled with the advancement in drug delivery technologies will drive retinal vein occlusion therapeutics market growth at a CAGR of more than 9% during the forecast period.

Who are the Major Retinal Vein Occlusion Therapeutics Vendors?

The global retinal vein occlusion therapeutics market is highly concentrated. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by companies, this retinal vein occlusion therapeutics industry analysis report will aid clients identify new growth opportunities and design new growth strategies.

The report offers a detailed analysis of several leading retinal vein occlusion therapeutics companies, including:

  • Allergan  
  • Bayer  
  • F. Hoffmann-La Roche
  • Novartis
  • Regeneron Pharmaceuticals

What are the Major Type Segments in the Retinal Vein Occlusion Therapeutics Market?

  • BRVO
  • CRVO

BRVO was accounted for the largest global retinal vein occlusion therapeutics market share in 2018. The market share of this segment will continue to increase and the segment will dominate the market throughout the forecast period.

Which are the Key Markets for Retinal Vein Occlusion Therapeutics?

  • Americas
  • APAC
  • EMEA

The Americas accounted for the largest retinal vein occlusion therapeutics market share in 2018. This region will continue to offer maximum growth opportunities and contribute for the maximum retinal vein occlusion market growth in the coming years.

What are the Key Factors Covered in this Retinal Vein Occlusion Therapeutics Market Report?

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the retinal vein occlusion therapeutics market during the next five years
  • Precise estimation of the global retinal vein occlusion therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the retinal vein occlusion therapeutics industry across the Americas, APAC and EMEA
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of retinal vein occlusion therapeutics companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • BRVO - Market size and forecast 2018-2023
  • CRVO - Market size and forecast 2018-2023
  • Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALLERGAN 
  • Bayer 
  • F. Hoffmann-La Roche
  • Novartis
  • Regeneron Pharmaceuticals

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>